NPC Archive Item: Statins and risk of diabetes

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 01 March 2010 This meta-analysis found statin therapy was associated with a small increase in the absolute risk of developing diabetes. However, for people in whom statin therapy is […]

NPC Archive Item: Observational study of hypoglycaemic drugs has limitations

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 15th January 2010 Compared with metformin monotherapy, the fully adjusted analysis in this UK cohort study found no increased risk of heart failure or myocardial infarction with pioglitazone▼ or […]

NPC Archive Item: Study of insulin detemir should not deflect from NICE guidance

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 30 November 2009 This open label randomised trial suggests that using insulin detemir in people with type 2 diabetes leads to similar median HbA1c levels as twice daily biphasic […]

NPC Archive Item: More on glitazone safety: how do pioglitazone▼ and rosiglitazone compare?

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 2nd September 2009 Two recently published Canadian cohort studies have assessed cardiovascular safety and fracture risk with pioglitazone▼ and rosiglitazone. The BMJ study found pioglitazone▼ was associated with a […]

NPC Archive Item: Intensive glucose control in type 2 diabetes: conclusions unchanged

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 3rd August 2009 A meta-analysis of prospective randomised controlled trials suggests a small benefit of intensive glucose control in people with type 2 diabetes in reducing the risk of […]